Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization and adjustment of peginterferon antiviral schedules in HBeAg-positive chronic hepatitis B
ChiCTR1900020814Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of pegylated interferon alpha in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoints: HBsAg, serum HBeAg quantitation and 6 more. Started Jan 2019; status: recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR1900020814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020814.